Krystal Bergin
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk Groups.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 11, 2025
Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma.
Journal: Blood cancer journal
Published: September 10, 2024
Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21.
Journal: British journal of haematology
Published: December 19, 2023
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Journal: British journal of haematology
Published: March 31, 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice.
Journal: Frontiers in oncology
Published: November 23, 2021
Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience.
Journal: Internal medicine journal
Published: July 12, 2021
A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16-02 trial.
Journal: British journal of haematology
Published: January 14, 2021
TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing.
Journal: Leukemia & lymphoma
Published: November 02, 2020
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR).
Journal: Bone marrow transplantation
Published: October 21, 2020
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 19, 2020
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).
Journal: Leukemia & lymphoma
Published: June 12, 2019
Last Updated: 09/26/2026